Skip to main content

Olmesartan Medoxomil (International)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09CA08

CAS registry number (Chemical Abstracts Service)

0144689-63-4

Chemical Formula

C29-H30-N6-O6

Molecular Weight

559

Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Names

2,3-Dihydroxy-2-butenyl 4-(1-hydroxy-1-metyletyl)-2-propyl-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, cyclic 2,3-carbonate (WHO)

4-(1-hydroxy-1-metyletyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4 -yl)metyl)-1H-imidazole-5-carboxylic acid, (5-metyl-2-oxo-1,3-dioxol-4-yl)metyl ester

5-Metyl-2-oxo-1,3-dioxol-4-ylmetyl-4-(1-hydroxy-1-metyletyl)-2-propyl-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmetyl]imidazol-5-carboxylat (IUPAC)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.